Cited by 249Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

The DOI matches its Crossref record; 67 of the 73 references it cites were found in a registry or an index.

Brain dopamine transporter levels in treatment and drug naive adults with ADHD

Volkow, Nora D., Wang, Gene-Jack, Newcorn, Jeffrey, Fowler, Joanna S., Telang, Frank, Solanto, Mary V., Logan, Jean, Wong, Christopher, Ma, Yeming, Swanson, James M., Schulz, Kurt, Pradhan, Kith·2007·NeuroImage

DOI 10.1016/j.neuroimage.2006.10.014

Open this paper in CoChat — free account

Abstract

Attention deficit hyperactivity disorder (ADHD) is the most frequent psychiatric disorder in children, yet data are sparse on its pathophysiology. Particularly relevant are the dopamine transporters since these are the main targets of stimulant medications used for ADHD treatment. Though some imaging studies have shown increases in dopamine transporters in ADHD others have not and their role in the neurobiology of ADHD remains unclear. Here we investigate dopamine transporters in ADHD subjects with control of potentially confounding factors (previous medication and/or drug histories, comorbidity) and their association with clinical symptoms. Positron emission tomography and [11C]cocaine were used to measure dopamine transporters in 20 never medicated adults with ADHD and 25 controls. Dopamine transporters were lower in left caudate (13%, p < 0.05) and in left nucleus accumbens (p < 0.005) in ADHD subjects than in controls. In putamen dopamine transporters did not differ between groups but were associated with scores of inattention (Conners Adult Attention Rating Scale) both in ADHD subjects (p < 0.005) and in controls (p < 0.005). Thus, for a given transporter level the scores for inattention were on average five times greater in ADHD subjects than in controls. These results do not corroborate increases in dopamine transporters in ADHD subjects and show that in some they are reduced. It also provides evidence that dopamine transporter levels modulate attention but suggest that additional pathology (e.g., prefrontal or cingulostriatal pathways, noradrenergic neurotransmission) is necessary to account for the large differences in inattention observed between controls and ADHD subjects.

Integrity signals

Registry

Crossref · 10.1016/j.neuroimage.2006.10.014

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A rating scale for depression
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Statistical parametric maps in functional imaging: A general linear approach
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688
Co-planar stereotaxic atlas of the human brain
Laitinen, L. (1989) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(89)90128-5 · Cited by 7,565
Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes
Castellanos, F. X., & Tannock, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn896 · Cited by 1,827 · cited 1×
“However, other factors such as ADHD subtypes or genotypes may also affect DAT (Castellanos and Tannock, 2002; Pliszka et al., 1996).”
Background
Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type
Biederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498
Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [ N - 11 C-Methyl]-(−)-Cocaine PET Studies in Human Subjects
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., HITZEMANN, R. J., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,481
Self-citation
Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder
Castellanos, F. X. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830070053009 · Cited by 1,183
a dynamic developmental theory of attention-deficit/hyperactivity disorder (adhd) predominantly hyperactive/impulsive and combined subtypes
sagvolden, T., johansen, E. B., aase, H., & russell, V. A. (2005) · Behavioral and Brain Sciences · doi:10.1017/s0140525x05000075 · Cited by 1,035

Flagged first, then by citations

Show all 73 references

6 of the 73 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Conners, 1998, Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring, J. Clin. Psychiatry, 59, 24
Hesse, 2006, The striatal dopamine transporter availability is reduced in adults with attention-deficit/hyperactivity disorder, J. Nucl. Med., 47, 142
National Institutes of Health (NIH), 2000, Consensus Development Conference Statement: diagnosis and treatment of attention deficit/hyperactivity disorder (ADHD), J. Am. Acad. Child Adolesc. Psych., 39, 192

Sorted by citations

Imaging dopamine's role in drug abuse and addiction
Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988
Self-citation
Insights into the neural basis of response inhibition from cognitive and clinical neuroscience
Chambers, C. D., Garavan, H., & Bellgrove, M. A. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.016 · Cited by 938
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928
“Fronto-striatal dysfunction and increased dopamine transporter density in the striatum have both been reported [83-86] although the finding of increased dopamine transporter density remains a controversial finding, perhaps secondary to drug treatments for ADHD [87,88].”
Evaluating Dopamine Reward Pathway in ADHD: Clinical Implications
Volkow, N. D., Wang, G.-J., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F., Fowler, J. S., Zhu, W., Logan, J., Ma, Y., et al. (2009) · JAMA · doi:10.1001/jama.2009.1308 · Cited by 728
Self-citation
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., Nunes Filipe, C., et al. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.11.001 · Cited by 686
The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder
del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.036 · Cited by 685
Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes
Elia, J., Gai, X., Xie, H. M., Perin, J. C., Geiger, E., Glessner, J. T., D'arcy, M., deBerardinis, R., Frackelton, E., Kim, C., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.57 · Cited by 529
Neurobiological Circuits Regulating Attention, Cognitive Control, Motivation, and Emotion: Disruptions in Neurodevelopmental Psychiatric Disorders
Arnsten, A. F. T., & Rubia, K. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.01.008 · Cited by 568
Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals.
Smith, M. E., & Farah, M. J. (2011) · Psychological Bulletin · doi:10.1037/a0023825 · Cited by 456
Attention-Deficit/Hyperactivity Disorder and Attention Networks
Bush, G. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.120 · Cited by 358
The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder
Han, D. H., Lee, Y. S., Na, C., Ahn, J. Y., Chung, U., Daniels, M. A., Haws, C. A., & Renshaw, P. F. (2008) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2008.08.011 · Cited by 355
Depressed Dopamine Activity in Caudate and Preliminary Evidence of Limbic Involvement in Adults With Attention-Deficit/Hyperactivity Disorder
Volkow, N. D., Wang, G.-J., Newcorn, J., Telang, F., Solanto, M. V., Fowler, J. S., Logan, J., Ma, Y., Schulz, K., Pradhan, K., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.8.932 · Cited by 331
Self-citation
Disorder-Specific Dissociation of Orbitofrontal Dysfunction in Boys With Pure Conduct Disorder During Reward and Ventrolateral Prefrontal Dysfunction in Boys With Pure ADHD During Sustained Attention
Rubia, K., Smith, A. B., Halari, R., Matsukura, F., Mohammad, M., Taylor, E., & Brammer, M. J. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08020212 · Cited by 322
Developmental phenotypes and causal pathways in attention deficit/hyperactivity disorder: potential targets for early intervention?
Sonuga‐Barke, E. J. S., & Halperin, J. M. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2009.02195.x · Cited by 320
Cingulate, Frontal, and Parietal Cortical Dysfunction in Attention-Deficit/Hyperactivity Disorder
Bush, G. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.022 · Cited by 304
Effects of Methylphenidate on the Catecholaminergic System in Attention-Deficit/Hyperactivity Disorder
Wilens, T. E. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318173312f · Cited by 269
Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of Progress
Swanson, J., Baler, R. D., & Volkow, N. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.160 · Cited by 252
Self-citation
Atypical prefrontal connectivity in attention-deficit/hyperactivity disorder: pathway to disease or pathological end point?
Liston, C., Cohen, M. M., Teslovich, T., Levenson, D., & Casey, B. J. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.022 · Cited by 216
ADHD and the Prefrontal Cortex
Arnsten, A. F. T. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.01.018 · Cited by 220
Multidisciplinary perspectives on attention and the development of self-regulation
Berger, A., Kofman, O., Livneh, U., & Henik, A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.06.004 · Cited by 199
The Potential for Misuse and Abuse of Medications in ADHD: A Review
Clemow, D. B., & Walker, D. J. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.09.2801 · Cited by 198
Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task
Bush, G., Spencer, T. J., Holmes, J., Shin, L. M., Valera, E. M., Seidman, L. J., Makris, N., Surman, C., Aleardi, M., Mick, E., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.16 · Cited by 201
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease
German, C. L., Baladi, M. G., McFadden, L. M., Hanson, G. R., & Fleckenstein, A. E. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010397 · Cited by 207
ADHD and Smoking
McClernon, F. J., & Kollins, S. H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.016 · Cited by 195
Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter
Salahpour, A., Ramsey, A., Medvedev, I., Kile, B. M., Sotnikova, T. D., Holmstrand, E., Ghisi, V., Nicholls, P., Wong, L., Murphy, K. L., et al. (2008) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0707646105 · Cited by 189
Methylphenidate Normalizes Fronto-Striatal Underactivation During Interference Inhibition in Medication-Naïve Boys with Attention-Deficit Hyperactivity Disorder
Rubia, K., Halari, R., Cubillo, A., Smith, A. B., Mohammad, A.-M., Brammer, M., & Taylor, E. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.30 · Cited by 184
Overview of Animal Models of Attention Deficit Hyperactivity Disorder (ADHD)
Russell, V. A. (2011) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0935s54 · Cited by 182
Methylphenidate Normalizes Frontocingulate Underactivation During Error Processing in Attention-Deficit/Hyperactivity Disorder
Rubia, K., Halari, R., Mohammad, A.-M., Taylor, E., & Brammer, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.018 · Cited by 171
Dopamine–serotonin interactions in attention-deficit hyperactivity disorder (ADHD)
Oades, R. D. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00926-6 · Cited by 167
Dopamine Transporters in Striatum Correlate with Deactivation in the Default Mode Network during Visuospatial Attention
Tomasi, D., Volkow, N. D., Wang, R., Telang, F., Wang, G.-J., Chang, L., Ernst, T., & Fowler, J. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006102 · Cited by 154
Self-citation
Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder
Wang, G.-J., Volkow, N. D., Wigal, T., Kollins, S. H., Newcorn, J. H., Telang, F., Logan, J., Jayne, M., Wong, C. T., Han, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063023 · Cited by 144
Self-citation
Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder
Richardson, J. R., Taylor, M., Shalat, S. L., Guillot, T. S., Caudle, W. M., Hossain, M. M., Mathews, T. A., Jones, S. R., Cory‐Slechta, D. A., & Miller, G. W. (2015) · The FASEB Journal · doi:10.1096/fj.14-260901 · Cited by 148
Perinatal Dietary Polyunsaturated Fatty Acids in Brain Development, Role in Neurodevelopmental Disorders
Martinat, M., Rossitto, M., Miceli, M. D., & Layé, S. (2021) · Nutrients · doi:10.3390/nu13041185 · Cited by 152
Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses
Genro, J. P., Kieling, C., Rohde, L. A., & Hutz, M. H. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.17 · Cited by 139
Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD
Thome, J., Ehlis, A.-C., Fallgatter, A. J., Krauel, K., Lange, K. W., Riederer, P., Romanos, M., Taurines, R., Tucha, O., Uzbekov, M., et al. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.690535 · Cited by 130
Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD)
Schmidt, S., & Petermann, F. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-58 · Cited by 129
In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders
Nikolaus, S., Antke, C., & Müller, H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.009 · Cited by 128
Clinical approaches to treatment of Internet addiction
Przepiórka, A., Błachnio, A., Miziak, B., & Czuczwar, S. J. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.10.001 · Cited by 116
An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder
da Silva, B. S., Grevet, E. H., Silva, L. C. F., Ramos, J. K. N., Rovaris, D. L., & Bau, C. H. D. (2023) · Discover Mental Health · doi:10.1007/s44192-022-00030-1 · Cited by 146
A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment
del Campo, N., Fryer, T. D., Hong, Y. T., Smith, R., Brichard, L., Acosta-Cabronero, J., Chamberlain, S. R., Tait, R., Izquierdo, D., Regenthal, R., et al. (2013) · Brain · doi:10.1093/brain/awt263 · Cited by 113
SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder
Krause, J. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.611 · Cited by 110
Dopaminergic and GABA‐ergic markers of impulsivity in rats: evidence for anatomical localisation in ventral striatum and prefrontal cortex
Jupp, B., Caprioli, D., Saigal, N., Reverte, I., Shrestha, S., Cumming, P., Everitt, B. J., Robbins, T. W., & Dalley, J. W. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12146 · Cited by 109
Emerging Association Between Addictive Gaming and Attention-Deficit/Hyperactivity Disorder
Weinstein, A. M., & Weizman, A. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0311-x · Cited by 116
The brain anatomy of attention-deficit/hyperactivity disorder in young adults—a magnetic resonance imaging study
Gehricke, J.-G., Kruggel, F., Thampipop, T., Alejo, S. D., Tatos, E., Fallon, J., & Muftuler, L. T. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175433 · Cited by 103
Brainstem abnormalities in attention deficit hyperactivity disorder support high accuracy individual diagnostic classification
Johnston, B. A., Mwangi, B., Matthews, K., Coghill, D., Konrad, K., & Steele, J. D. (2014) · Human Brain Mapping · doi:10.1002/hbm.22542 · Cited by 101
The dopamine hypothesis for ADHD: An evaluation of evidence accumulated from human studies and animal models
MacDonald, H. J., Kleppe, R., Szigetvari, P. D., & Haavik, J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1492126 · Cited by 124
The relationship between cognitive performance and electrophysiological indices of performance monitoring
Larson, M. J., & Clayson, P. E. (2010) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-010-0018-6 · Cited by 106
Biological and social influences on cognitive control processes dependent on prefrontal cortex
Diamond, A. D. (2011) · Progress in brain research · doi:10.1016/b978-0-444-53884-0.00032-4 · Cited by 117
ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: Implications for smoking and nicotine dependence
Kollins, S. H., & Adcock, R. A. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.02.002 · Cited by 95
Neural substrates of trait impulsivity, anhedonia, and irritability: Mechanisms of heterotypic comorbidity between externalizing disorders and unipolar depression
Zisner, A. R., & Beauchaine, T. P. (2016) · Development and Psychopathology · doi:10.1017/s0954579416000754 · Cited by 101
Comorbidity of ADHD and Substance Use Disorder (SUD): A Neuroimaging Perspective
Frodl, T. (2010) · Journal of Attention Disorders · doi:10.1177/1087054710365054 · Cited by 87
Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology
McNamara, R. K. (2015) · World Journal of Psychiatry · doi:10.5498/wjp.v5.i1.15 · Cited by 88
Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function
Harvey, R. C., Sen, S., Deaciuc, A., Dwoskin, L. P., & Kantak, K. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.223 · Cited by 86
Transgenic mouse models for ADHD
Leo, D., & Gainetdinov, R. R. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1639-1 · Cited by 86
Molecular Genetics of Attention
Bellgrove, M. A., & Mattingley, J. B. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.013 · Cited by 85
Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: A 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study
Ludolph, A. G., Kassubek, J., Schmeck, K., Glaser, C., Wunderlich, A., Buck, A. K., Reske, S. N., Fegert, J. M., & Mottaghy, F. M. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.02.025 · Cited by 83
Mechanisms of comorbidity, continuity, and discontinuity in anxiety-related disorders
McNaughton, N., & Corr, P. J. (2016) · Development and Psychopathology · doi:10.1017/s0954579416000699 · Cited by 81
The dopaminergic hypothesis of attention-deficit/hyperactivity disorder needs re-examining
Gonon, F. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.010 · Cited by 79
Psychopharmacology: concepts and opinions about the use of stimulant medications
Swanson, J. M., & Volkow, N. D. (2009) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2008.02062.x · Cited by 78
Self-citation
How effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphetamine
Roberts, C. A., Jones, A., Sumnall, H., Gage, S. H., & Montgomery, C. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.07.002 · Cited by 78
Irrelevant stimulus processing in ADHD: catecholamine dynamics and attentional networks
Aboitiz, F., Ossandón, T., Zamorano, F. J., Palma, B. A., & Carrasco, X. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00183 · Cited by 86
Why Most Biomedical Findings Echoed by Newspapers Turn Out to be False: The Case of Attention Deficit Hyperactivity Disorder
Gonon, F., Konsman, J. P., Cohen, D., & Boraud, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044275 · Cited by 85
Misrepresentation of Neuroscience Data Might Give Rise to Misleading Conclusions in the Media: The Case of Attention Deficit Hyperactivity Disorder
Gonon, F., Bezard, E., & Boraud, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014618 · Cited by 71
Imaging genetics in ADHD
Durston, S. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.071 · Cited by 77
Sugar consumption and attention-deficit/hyperactivity disorder (ADHD): A birth cohort study
Del‐Ponte, B., Anselmi, L., Assunção, M. C. F., Tovo‐Rodrigues, L., Munhoz, T. N., Matijasevich, A., Rohde, L. A., & Santos, I. S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.051 · Cited by 68
What Is the Link Between Attention-Deficit/Hyperactivity Disorder and Sleep Disturbance? A Multimodal Examination of Longitudinal Relationships and Brain Structure Using Large-Scale Population-Based Cohorts
Shen, C., Luo, Q., Chamberlain, S. R., Morgan, S. E., Romero-García, R., Du, J., Zhao, X., Touchette, É., Montplaisir, J. Y., Vitaro, F., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.010 · Cited by 76
Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder
Hesse, S., Ballaschke, O., Barthel, H., & Sabri, O. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.01.002 · Cited by 70
Methylphenidate Effects on Neural Activity During Response Inhibition in Healthy Humans
Costa, A. C. L., Riedel, M. J., Pogarell, O. M., Menzel-Zelnitschek, F., Schwarz, M., Reiser, M. F., Möller, H., Rubia, K., Meindl, T., & Ettinger, U. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs107 · Cited by 70
Good riddance to dopamine: Roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders
Gowrishankar, R., Hahn, M. K., & Blakely, R. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.10.016 · Cited by 66
Neonatal 6-OHDA lesion model in mouse induces Attention-Deficit/ Hyperactivity Disorder (ADHD)-like behaviour
Bouchatta, O., Manouze, H., Bouali‐Benazzouz, R., Kerekes, N., Ba-M’hamed, S., Fossat, P., Landry, M., & Bennis, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-33778-0 · Cited by 65
Role of Aberrant Striatal Dopamine D1Receptor/cAMP/Protein Kinase A/DARPP32 Signaling in the Paradoxical Calming Effect of Amphetamine
Napolitano, F., Bonito-Oliva, A., Federici, M., Carta, M., Errico, F., Magara, S., Martella, G., Nisticò, R., Centonze, D., Pisani, A., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1682-10.2010 · Cited by 65
The interaction between reinforcement and inhibitory control in ADHD: A review and research guidelines
Ma, I., van Duijvenvoorde, A. C. K., & Scheres, A. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.01.001 · Cited by 71
Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD
Johnson, K. A., Barry, E., Bellgrove, M. A., Cox, M., Kelly, S. P., Dáibhis, A., Daly, M., Keavey, M., Watchorn, A., Fitzgerald, M., et al. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.01.002 · Cited by 62
The Norepinephrine Transporter in Attention-Deficit/Hyperactivity Disorder Investigated With Positron Emission Tomography
Vanicek, T., Spies, M., Rami-Mark, C., Savli, M., Höflich, A., Kranz, G. S., Hahn, A., Kutzelnigg, A., Traub-Weidinger, T., Mitterhauser, M., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1226 · Cited by 61
Self-citation
Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders
Virdee, K., Cumming, P. D., Caprioli, D., Jupp, B., Rominger, A., Aigbirhio, F. I., Fryer, T. D., Riss, P. J., & Dalley, J. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.01.009 · Cited by 61
Entwicklungspsychopathologie der ADHS
Schmidt, S., & Petermann, F. (2008) · Zeitschrift für Psychiatrie Psychologie und Psychotherapie · doi:10.1024/1661-4747.56.4.265 · Cited by 59
Positron emission tomography neuroimaging for a better understanding of the biology of ADHD
Zimmer, L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.001 · Cited by 63
Increased default-mode variability is related to reduced task-performance and is evident in adults with ADHD
Mowinckel, A. M., Alnæs, D., Pedersen, M. L., Ziegler, S., Fredriksen, M., Kaufmann, T., Sonuga-Barke, E. J. S., Endestad, T., Westlye, L. T., & Biele, G. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.03.008 · Cited by 71
Acute neuropharmacological effects of atomoxetine on inhibitory control in ADHD children: A fNIRS study
Nagashima, M., Monden, Y., Dan, I., Dan, H., Tsuzuki, D., Mizutani, T., Kyutoku, Y., Gunji, Y., Hirano, D., Taniguchi, T., et al. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.09.001 · Cited by 63
Dissociable Rate-Dependent Effects of Oral Methylphenidate on Impulsivity and D2/3Receptor Availability in the Striatum
Caprioli, D., Jupp, B., Hong, Y. T., Sawiak, S. J., Ferrari, V., Wharton, L., Williamson, D. J., McNabb, C. B., Berry, D. W., Aigbirhio, F. I., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3890-14.2015 · Cited by 59
The dopamine transporter haplotype and reward-related striatal responses in adult ADHD
Hoogman, M., Onnink, A. M. H., Cools, R., Aarts, E., Kan, C. C., Vásquez, A. A., Buitelaar, J. K., & Franke, B. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.05.011 · Cited by 61
Genotype and ancestry modulate brain's DAT availability in healthy humans
Shumay, E., Chen, J., Fowler, J. S., & Volkow, N. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022754 · Cited by 58
Self-citation
Low Frequency Repetitive Transcranial Magnetic Stimulation in Children With Attention Deficit/Hyperactivity Disorder. Preliminary Results
Gómez, L., Vidal-Martínez, B., Morales, L. M., Báez, M., Maragoto, C., Sánchez, R. G., Vera, H., Abreu, I. C., Zaldívar, M., & Sánchez, A. (2014) · Brain stimulation · doi:10.1016/j.brs.2014.06.001 · Cited by 56
8.3 Imaging Dopamine’s Role in Drug Abuse and Addiction
Volkow, N. D., Fowler, J. S., Wang, G., Telang, F., & Baler, R. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0028 · Cited by 58
Self-citation
A prenatal nicotine exposure mouse model of methylphenidate responsive ADHD‐associated cognitive phenotypes
Zhu, J., Fan, F., McCarthy, D. M., Zhang, L., Cannon, E. N., Spencer, T. J., Biederman, J., & Bhide, P. G. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.01.014 · Cited by 54
Toward Defining the Neural Substrates of ADHD
Makris, N., Liang, L., Biederman, J., Valera, E. M., Brown, A., Petty, C. R., Spencer, T. J., Faraone, S. V., & Seidman, L. J. (2013) · Journal of Attention Disorders · doi:10.1177/1087054713506041 · Cited by 56
Amphetamine-induced dopamine release and neurocognitive function in treatment-naive adults with ADHD
Cherkasova, M. V., Faridi, N., Casey, K. F., O'Driscoll, G. A., Hechtman, L., Joober, R., Baker, G. B., Palmer, J., Dagher, A., Leyton, M., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.349 · Cited by 49
A comparison of phenylketonuria with attention deficit hyperactivity disorder: Do markedly different aetiologies deliver common phenotypes?
Stevenson, M. P., & McNaughton, N. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.10.003 · Cited by 51
Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD)
Kollins, S. H., English, J., Robinson, R., Hallyburton, M., & Chrisman, A. K. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1439-6 · Cited by 48
“This hypothesis is supported by studies showing differences in dopamine transporter (DAT) density in relevant striatal areas in ADHD patients compared to controls (Cheon et al. 2003; Dougherty et al. 1999; Dresel et al. 2000; Krause et al. 2000, 2002, 2003; Larisch et al. 2006; Spencer et al. 2005; Volkow et al. 2007).”
Misuse of Methylphenidate
Clemow, D. B. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_426 · Cited by 50
Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study
Wiers, C. E., Lohoff, F. W., Lee, J., Muench, C., Freeman, C. R., Zehra, A., Marenco, S., Lipska, B. K., Auluck, P. K., Feng, N., et al. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14067 · Cited by 51
Self-citation
Functional Brain Changes in Response to Treatment of Internet Gaming Disorder
Han, D. H., Kim, S. M., & Renshaw, P. F. (2015) · Studies in neuroscience, psychology and behavioral economics · doi:10.1007/978-3-319-07242-5_5 · Cited by 48
Spatial Attentional Bias as a Marker of Genetic Risk, Symptom Severity, and Stimulant Response in ADHD
Bellgrove, M. A., Barry, E., Johnson, K. A., Cox, M., Dáibhis, A., Daly, M., Hawi, Z., Lambert, D., Fitzgerald, M., McNicholas, F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301637 · Cited by 48
Neuroimaging of Attention Deficit Hyperactivity Disorder: Can New Imaging Findings Be Integrated in Clinical Practice?
Bush, G. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2007.11.002 · Cited by 46
Impulsive Behavior and Nicotinic Acetylcholine Receptors
Ohmura, Y., Tsutsui‐Kimura, I., & Yoshioka, M. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11r06cr · Cited by 47
Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis
Oliva, F., Mangiapane, C., Nibbio, G., Berchialla, P., Colombi, N., & Vigna‐Taglianti, F. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.11.021 · Cited by 47
Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D2 Autoreceptors Shapes the In Vivo Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559
Gowrishankar, R., Gresch, P. J., Davis, G. L., Katamish, R. M., Riele, J. R., Stewart, A., Vaughan, R. A., Hahn, M. K., & Blakely, R. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0055-18.2018 · Cited by 39
Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET: Serotonin Transporter in ADHD Revealed by PET
Vanicek, T., Kutzelnigg, A., Philippe, C., Sigurdardottir, H. L., James, G. M., Hahn, A., Kranz, G. S., Höflich, A., Kautzky, A., Traub-Weidinger, T., et al. (2017) · Human Brain Mapping · doi:10.1002/hbm.23418 · Cited by 44
Subcortico-cortical dysconnectivity in Attention Deficit/Hyperactivity Disorder: A voxelwise mega-analysis across multiple cohorts
Norman, L. J., Sudre, G., Price, J., & Shaw, P. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230026 · Cited by 37
Impulsivity is related to striatal dopamine transporter availability in healthy males
Costa, A. C. L., la Fougère, C. J., Pogarell, O. M., Möller, H., Riedel, M. J., & Ettinger, U. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.07.011 · Cited by 41

Authors: Volkow, N. D., Wang, G.-J., Newcorn, J., Fowler, J. S., Telang, F., Solanto, M. V., Logan, J., Wong, C., Ma, Y., Swanson, J. M., Schulz, K., & Pradhan, K.
Affiliations: National Institute on Drug Abuse (US)
Brookhaven National Laboratory (US)
Mount Sinai Hospital (US)
National Institute on Alcohol Abuse and Alcoholism (US)
University of California, Irvine (US)
State University of New York (US)
Corresponding author: Volkow, Nora D.
ORCID: Volkow, Nora D.
Wang, Gene-Jack
Newcorn, Jeffrey
Solanto, Mary V.
Logan, Jean
Wong, Christopher
Swanson, James M.
Schulz, Kurt
Pradhan, Kith
Venue: NeuroImage
Publisher: Elsevier BV
Published: 2007-02
Volume: 34
Issue: 3
Pages: 1182-1190
ISSN: 1053-8119 (ISSN-L)
DOI: 10.1016/j.neuroimage.2006.10.014
OpenAlex: W2082738856
Cited by: 249
References: 73
Citations by year: 2026: 5 · 2025: 7 · 2024: 9 · 2023: 7 · 2022: 9 · 2021: 7 · 2020: 11 · 2019: 4 · 2018: 12 · 2017: 10 · 2016: 11 · 2015: 13 · 2014: 24 · 2013: 14 · 2012: 22
FWCI: 11.29
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: NeuroImage (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute of Mental Health (MH66961-02, R01MH066961)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords: attention deficit hyperactivity disorder, dopamine transporter, caudate nucleus, nucleus accumbens, putamen, inattention, adult ADHD, neurobiology of ADHD, noradrenergic neurotransmission
MeSH terms: Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Brain, Carbon Radioisotopes, Cocaine, Female, Humans, Male, Tissue Distribution, Radiopharmaceuticals, Positron-Emission Tomography, Dopamine Plasma Membrane Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Brain dopamine transporter levels in treatment and drug naive adults with ADHD

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks